(Q54399617)

English

Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Adaptive radiation therapy

0 references

Christian Kirisits

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Richard Pötter

4

object named as

Richard Pötter

1 reference

Europe PubMed Central

29 May 2018

author name string

Gregor Goldner

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Johannes Dimopoulos

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

publication date

1 July 2009

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

185

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

438-445

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

https://scigraph.springernature.com/pub.10.1007/s00066-2009-2033-5

0 references

What dose of external-beam radiation is high enough for prostate cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS00066-2009-2033-5

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1007%2FS00066-2009-2033-5

21 January 2018

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1007%2FS00066-2009-2033-5

21 January 2018

Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1007%2FS00066-2009-2033-5

21 January 2018

Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in lymph node-positive prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guideline for the management of clinically localized prostate cancer: 2007 update.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arc

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helical tomotherapy. Experiences of the first 150 patients in Heidelberg

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Australian and New Zealand three-dimensional conformal radiation therapy consensus guidelines for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19714305

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-2009-2033-5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/19714305

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54399617&oldid=1403978000"